Clinical Trial Update: Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lumentin 44 as a diagnostic contrast agent completed for Crohn disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Lumentin 44

Snippet

Sponsor: Lument AB | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED